Janet L. Stringer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Janet L. Stringer has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Eric W. Lothman
Department of Neurology, University of Virginia Medical Center, Charlottesville, VA 22908, USA
3 shared publicationsEdward H. Bertram
2 shared publicationsXiao‐Yuan Lian
Department of Pharmacology, Baylor College of Medicine, Houston 77030, USA
2 shared publicationsZhi-Qi Xiong
Department of Pharmacology and Division of Neuroscience, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA
2 shared publicationsAhmed M Aribi
1 shared publicationAhmed M. Aribi
1 shared publication
Latest Publications
- 1 July 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (1) , 77-82
Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures
- 1 July 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (1) , 77-82
Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures
- 25 April 2005
- Published by Wiley in Annals of Neurology
- Vol. 57 (5) , 642-648
Protective effects of ginseng components in a rodent model of neurodegeneration
To test the proposed neuroprotective activity of whole ginseng extract and its components, we used 3‐nitropropionic acid (3‐NP), an inhibitor of succinate dehydrogenase, to produce neurodegeneration. Treatment with 3‐nitropropionic acid (90mg/kg) over a 5‐day period resulted in severe impairment of movement and loss of neurons in the striatum. Pretreatment with a preparation from the whole root of American ginseng had no protective effects. Pretreatment with a preparation of ground leaves and stems, which contains greater levels of ginsenosides than ground root, improved the behavioral score and reduced the volume of the striatal lesion. A partial purification of American ginseng was performed to concentrate the putative protective components: Rb1, Rb3, and Rd (termed Rb extract). Pretreatment with the Rb extract significantly reduced the 3‐nitropropionic acid–induced motor impairment and cell loss in the striatum, and it completely prevented any mortality. Significant effects on motor function, mortality, and the striatal lesion volume also were measured in animals pretreated with the individual ginsenosides, Rb1, Rb3, or Rd. The results demonstrate that some of the ginsenosides have neuroprotective activity, and that a partial purification of whole ginseng to concentrate the neuroprotective components may have utility as a neuroprotective agent. Ann Neurol 2005;57:642–648
- 25 April 2005
- Published by Wiley in Annals of Neurology
- Vol. 57 (5) , 642-648
Protective effects of ginseng components in a rodent model of neurodegeneration
To test the proposed neuroprotective activity of whole ginseng extract and its components, we used 3‐nitropropionic acid (3‐NP), an inhibitor of succinate dehydrogenase, to produce neurodegeneration. Treatment with 3‐nitropropionic acid (90mg/kg) over a 5‐day period resulted in severe impairment of movement and loss of neurons in the striatum. Pretreatment with a preparation from the whole root of American ginseng had no protective effects. Pretreatment with a preparation of ground leaves and stems, which contains greater levels of ginsenosides than ground root, improved the behavioral score and reduced the volume of the striatal lesion. A partial purification of American ginseng was performed to concentrate the putative protective components: Rb1, Rb3, and Rd (termed Rb extract). Pretreatment with the Rb extract significantly reduced the 3‐nitropropionic acid–induced motor impairment and cell loss in the striatum, and it completely prevented any mortality. Significant effects on motor function, mortality, and the striatal lesion volume also were measured in animals pretreated with the individual ginsenosides, Rb1, Rb3, or Rd. The results demonstrate that some of the ginsenosides have neuroprotective activity, and that a partial purification of whole ginseng to concentrate the neuroprotective components may have utility as a neuroprotective agent. Ann Neurol 2005;57:642–648
- Open Access
Anticonvulsant Activity of Ginseng on Seizures Induced by Chemical Convulsants
Summary: Purpose: To test the anticonvulsant activity of three preparations of American ginseng: whole root extract, whole leaves/stems extract, and a partially purified extract that concentrates the Rb ginsenosides (Rb extract). Methods: One hour after treatment with normal saline, or one of the three ginseng preparations, seizures were induced in adult, male, Sprague–Dawley rats with kainic acid (KA; 10 mg/kg), pilocarpine (300 mg/kg, preceded by methylscopolamine, 1 mg/kg, s.c.), or pentylenetetrazol (PTZ, 50 mg/kg). Time to onset of seizure activity, duration of seizure activity for PTZ, seizure severity, and weight change for KA and pilocarpine were determined for each animal. The brains from animals who had received KA or pilocarpine were examined for severe neuronal stress, by using immunoreactivity for heat‐shock protein (HSP)72. Results: The Rb extract had a dose‐dependent anticonvulsant effect in all three models of chemically induced seizures: increasing the latency to the seizures; decreasing the seizure score, weight loss, and subsequent neuronal damage after pilocarpine; and shortening the seizure duration and reducing mortality after PTZ. The Rb extract also significantly reduced the effects of KA, including completely blocking behavioral seizures. The root preparation increased the mortality rate after administration of pilocarpine, but had no other significant effects. The leaves/stems preparation, at 120 mg/kg, reduced the weight loss after pilocarpine, but had no other significant effects. Conclusions: Ginseng extract made from either the root or leaves/stems is ineffective against chemically induced seizures. A partial purification of the whole extract that concentrates the Rb1 and Rb3 ginsenosides has significant anticonvulsant properties.
Open AccessAnticonvulsant Activity of Ginseng on Seizures Induced by Chemical Convulsants
Summary: Purpose: To test the anticonvulsant activity of three preparations of American ginseng: whole root extract, whole leaves/stems extract, and a partially purified extract that concentrates the Rb ginsenosides (Rb extract). Methods: One hour after treatment with normal saline, or one of the three ginseng preparations, seizures were induced in adult, male, Sprague–Dawley rats with kainic acid (KA; 10 mg/kg), pilocarpine (300 mg/kg, preceded by methylscopolamine, 1 mg/kg, s.c.), or pentylenetetrazol (PTZ, 50 mg/kg). Time to onset of seizure activity, duration of seizure activity for PTZ, seizure severity, and weight change for KA and pilocarpine were determined for each animal. The brains from animals who had received KA or pilocarpine were examined for severe neuronal stress, by using immunoreactivity for heat‐shock protein (HSP)72. Results: The Rb extract had a dose‐dependent anticonvulsant effect in all three models of chemically induced seizures: increasing the latency to the seizures; decreasing the seizure score, weight loss, and subsequent neuronal damage after pilocarpine; and shortening the seizure duration and reducing mortality after PTZ. The Rb extract also significantly reduced the effects of KA, including completely blocking behavioral seizures. The root preparation increased the mortality rate after administration of pilocarpine, but had no other significant effects. The leaves/stems preparation, at 120 mg/kg, reduced the weight loss after pilocarpine, but had no other significant effects. Conclusions: Ginseng extract made from either the root or leaves/stems is ineffective against chemically induced seizures. A partial purification of the whole extract that concentrates the Rb1 and Rb3 ginsenosides has significant anticonvulsant properties.
- 10 May 2004
- Published by Elsevier in Brain Research
- Vol. 1012 (1-2) , 177-184
Astrocytes contribute to regulation of extracellular calcium and potassium in the rat cerebral cortex during spreading depression
- 10 May 2004
- Published by Elsevier in Brain Research
- Vol. 1012 (1-2) , 177-184
Astrocytes contribute to regulation of extracellular calcium and potassium in the rat cerebral cortex during spreading depression
- 23 February 2004
- Published by Wiley in Journal of Comparative Neurology
- Vol. 471 (3) , 289-297
Presence and induction of the enzyme NAD(P)H: Quinone oxidoreductase 1 in the central nervous system
NAD(P)H:quinone oxidoreductase 1 (NQO1) catalyzes a reductive detoxification that is thought to protect cells against the adverse effects of quinones and related compounds. NQO1 activity is present in all tissues. Absence of the enzyme produces abnormalities in the redox state and seizures, suggesting an important role of the protein in the central nervous system. Immunohistochemical analysis showed that the protein was found throughout the brain of the adult rat and mouse, with complete absence of the protein in brains from NQO1‐/‐ mice. NQO1 was not seen in any neuronal population, but was localized to Bergmann glial in the cerebellum and a subset of the oligodendrocytes throughout the brain. Prolonged seizures induced in adult rats with kainic acid resulted in an increase in activity of the enzyme throughout the brain, most prominently in the cerebellum, but immunoreactivity did not appear in neurons. Comparison of the axons in the corpus callosum from a wild‐type mouse to a knockout mouse showed that myelin is produced in the absence of NQO1, but there appears to be more small‐diameter axons in the knockout animal. These results suggest that NQO1 has a role in myelination in the central nervous system or in the insulating/wrapping function of glial cells. J. Comp. Neurol. 471:289–297, 2004.
- 23 February 2004
- Published by Wiley in Journal of Comparative Neurology
- Vol. 471 (3) , 289-297
Presence and induction of the enzyme NAD(P)H: Quinone oxidoreductase 1 in the central nervous system
NAD(P)H:quinone oxidoreductase 1 (NQO1) catalyzes a reductive detoxification that is thought to protect cells against the adverse effects of quinones and related compounds. NQO1 activity is present in all tissues. Absence of the enzyme produces abnormalities in the redox state and seizures, suggesting an important role of the protein in the central nervous system. Immunohistochemical analysis showed that the protein was found throughout the brain of the adult rat and mouse, with complete absence of the protein in brains from NQO1‐/‐ mice. NQO1 was not seen in any neuronal population, but was localized to Bergmann glial in the cerebellum and a subset of the oligodendrocytes throughout the brain. Prolonged seizures induced in adult rats with kainic acid resulted in an increase in activity of the enzyme throughout the brain, most prominently in the cerebellum, but immunoreactivity did not appear in neurons. Comparison of the axons in the corpus callosum from a wild‐type mouse to a knockout mouse showed that myelin is produced in the absence of NQO1, but there appears to be more small‐diameter axons in the knockout animal. These results suggest that NQO1 has a role in myelination in the central nervous system or in the insulating/wrapping function of glial cells. J. Comp. Neurol. 471:289–297, 2004.
- 1 May 2003
- Published by Elsevier in Epilepsy Research
- Vol. 54 (2-3) , 163-170
Effects of glial toxins on extracellular acidification in the hippocampal CA1 region in vivo
- 1 May 2003
- Published by Elsevier in Epilepsy Research
- Vol. 54 (2-3) , 163-170
Effects of glial toxins on extracellular acidification in the hippocampal CA1 region in vivo
- 1 December 2002
- Published by Elsevier in Epilepsy Research
- Vol. 52 (2) , 129-137
Modulation of the in vivo effects of gabapentin by vigabatrin and SKF89976A
- 1 December 2002
- Published by Elsevier in Epilepsy Research
- Vol. 52 (2) , 129-137
Modulation of the in vivo effects of gabapentin by vigabatrin and SKF89976A
- 25 August 2002
- Published by Elsevier in Developmental Brain Research
- Vol. 138 (1) , 81-86
Developmental expression of serum response factor in the rat central nervous system
- 25 August 2002
- Published by Elsevier in Developmental Brain Research
- Vol. 138 (1) , 81-86
Developmental expression of serum response factor in the rat central nervous system
- 10 November 2000
- Published by Elsevier in Neuropharmacology
- Vol. 40 (1) , 131-138
Effects of postsynaptic GABAB receptor activation on epileptiform activity in hippocampal slices
- 10 November 2000
- Published by Elsevier in Neuropharmacology
- Vol. 40 (1) , 131-138
Effects of postsynaptic GABAB receptor activation on epileptiform activity in hippocampal slices
- 1 August 2000
- Published by Elsevier in Epilepsy Research
- Vol. 41 (2) , 155-162
The effects of gabapentin in the rat hippocampus are mimicked by two structural analogs, but not by nimodipine
- 1 August 2000
- Published by Elsevier in Epilepsy Research
- Vol. 41 (2) , 155-162
The effects of gabapentin in the rat hippocampus are mimicked by two structural analogs, but not by nimodipine